Latest News for CPHRF
WASHINGTON--(BUSINESS WIRE)-- #DTP--CaryHealth, a leading digital health company, today announced the launch of its direct-to-patient (DTP) platform to support seamless access to Natroba (spinosad), a prescription treatment for head lice and scabies, in partnership with Cipher Pharmaceuticals US LLC (Cipher or Cipher Pharmaceuticals). Through this partnership, CaryHealth has designed an online custom platform to…
Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF - Get Free Report) (TSE: CPH)'s share price passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $11.18 and traded as high as $13.28. Cipher Pharmaceuticals shares last traded at $13.00, with a volume of 8,501 shares traded. Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc. (CPH:CA) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CPHRF.
Senate Trading
No Senate trades found for CPHRF.
U.S. House Trading
No House trades found for CPHRF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.